作者
Joshua D Cohen, Ammar A Javed, Christopher Thoburn, Fay Wong, Jeanne Tie, Peter Gibbs, C Max Schmidt, Michele T Yip-Schneider, Peter J Allen, Mark Schattner, Randall E Brand, Aatur D Singhi, Gloria M Petersen, Seung-Mo Hong, Song Cheol Kim, Massimo Falconi, Claudio Doglioni, Matthew J Weiss, Nita Ahuja, Jin He, Martin A Makary, Anirban Maitra, Samir M Hanash, Marco Dal Molin, Yuxuan Wang, Lu Li, Janine Ptak, Lisa Dobbyn, Joy Schaefer, Natalie Silliman, Maria Popoli, Michael G Goggins, Ralph H Hruban, Christopher L Wolfgang, Alison P Klein, Cristian Tomasetti, Nickolas Papadopoulos, Kenneth W Kinzler, Bert Vogelstein, Anne Marie Lennon
发表日期
2017/9/19
期刊
Proceedings of the National Academy of Sciences
卷号
114
期号
38
页码范围
10202-10207
出版商
National Academy of Sciences
简介
The earlier diagnosis of cancer is one of the keys to reducing cancer deaths in the future. Here we describe our efforts to develop a noninvasive blood test for the detection of pancreatic ductal adenocarcinoma. We combined blood tests for KRAS gene mutations with carefully thresholded protein biomarkers to determine whether the combination of these markers was superior to any single marker. The cohort tested included 221 patients with resectable pancreatic ductal adenocarcinomas and 182 control patients without known cancer. KRAS mutations were detected in the plasma of 66 patients (30%), and every mutation found in the plasma was identical to that subsequently found in the patient’s primary tumor (100% concordance). The use of KRAS in conjunction with four thresholded protein biomarkers increased the sensitivity to 64%. Only one of the 182 plasma samples from the control cohort was positive for …
学术搜索中的文章
JD Cohen, AA Javed, C Thoburn, F Wong, J Tie… - Proceedings of the National Academy of Sciences, 2017